top of page

Medullary Thyroid Cancer: Symptoms, Genetics, and Treatment Options

Sep 28
6 min read

Updated: Nov 11

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

Quick Answer

Medullary thyroid cancer (MTC) is a thyroid cancer that arises from calcitonin-producing C cells. [1] Symptoms often include a thyroid nodule or swollen neck lymph nodes. [1] About 75% of cases are sporadic and 25% are inherited through MEN2. Treatment typically involves a total thyroidectomy followed by lifelong hormone replacement, and it is often curable if caught early.

What the research says

  • A targeted RET pill beat older drugs. In a phase 3 trial of 291 people with advanced RET-mutant medullary thyroid cancer, selpercatinib cut the risk of cancer growth or death by 72% compared with cabozantinib or vandetanib. At 12 months, 86.8% vs 65.7% had no progression, and tumors shrank in 69.4% vs 38.8% (Hadoux et al., The New England Journal of Medicine, 2023) [3].

  • Vandetanib slowed advanced disease. In a trial of 331 people with advanced medullary thyroid cancer, vandetanib lowered the risk of disease progression by 54% compared with placebo. Diarrhea (56% vs 26%), rash and high blood pressure were more common on the drug (Wells et al., Journal of Clinical Oncology, 2012) [4].

What is Medullary Thyroid Cancer?

Medullary thyroid cancer (MTC) is a rare malignancy that forms in the interior portion of the thyroid gland, known as the medulla. Unlike more common thyroid cancers that originate in follicular cells, MTC arises from parafollicular C cells. These specialized cells are responsible for producing calcitonin, a hormone involved in calcium regulation. When these C cells grow uncontrollably, they form a tumor within the thyroid.

MTC accounts for approximately 4% to 10% of all thyroid cancer diagnoses in the United States, with roughly 1,000 new cases identified annually. While the diagnosis can be concerning due to its rarity, medical advancements have provided several effective therapeutic pathways for managing the condition.

What are the symptoms and warning signs of medullary thyroid cancer?

In many instances, medullary thyroid cancer progresses slowly and may remain asymptomatic for an extended period while the tumor is small. When symptoms do emerge, they are most frequently related to the physical presence of a mass in the neck area.

  • Thyroid Nodule (Lump): present in 75% to 95% of patients at diagnosis.

  • Swollen Neck Lymph Nodes: present in approximately 70% of patients at diagnosis.

In rare or more advanced cases, a large thyroid nodule may press against nearby structures, leading to hoarseness, difficulty swallowing (dysphagia), or breathing challenges. These symptoms warrant immediate evaluation by a healthcare professional.

A professional medical illustration showing the location of the thyroid gland in the neck and the internal medulla where medullary thyroid cancer (MTC) develops from C cells. – rinnit.com

What causes medullary thyroid cancer, and what genetic factors are involved?

The causes of medullary thyroid cancer are divided into two primary categories: sporadic and inherited. Understanding the origin of the cancer is essential for determining the appropriate screening and treatment plan for both the patient and their family.

Sporadic vs. Inherited MTC

  • Sporadic MTC (75% of cases): These occur randomly in individuals with no family history of the disease. While the exact cause is often unknown, nearly half of these patients have acquired mutations in the RET gene later in life.

  • Inherited MTC (25% of cases): This form is linked to Multiple Endocrine Neoplasia type 2 (MEN2). Patients with MEN2A have a 90% chance of developing MTC, while those with MEN2B have a near 100% chance, often at a very young age.

Because of the strong genetic link in inherited cases, providers often recommend genetic testing for patients and their biological family members to identify potential risks early.

An educational infographic explaining the difference between sporadic and inherited medullary thyroid cancer, highlighting the role of the RET gene and MEN2 syndrome. – rinnit.com

How is medullary thyroid cancer diagnosed and tested?

Medullary thyroid cancer is often discovered during a routine neck examination or incidentally during imaging for other health concerns. If a nodule is detected, several diagnostic steps are taken to confirm the presence of MTC.

  1. Imaging Tests: Ultrasounds, CT scans, and MRIs are used to visualize the nodule and determine if it has spread to nearby lymph nodes. [2]

  2. Fine Needle Aspiration (Biopsy): A thin needle is used to extract a small tissue sample from the thyroid nodule for microscopic analysis. [2]

  3. Blood Tests: Providers measure levels of calcitonin and carcinoembryonic antigen (CEA). Elevated levels of these markers are characteristic of MTC and are also used to monitor treatment progress.

How is medullary thyroid cancer treated and managed?

The primary treatment for medullary thyroid cancer is surgical intervention. Because MTC originates in the medulla and can be aggressive, a total thyroidectomy (the complete removal of the thyroid gland) is typically required.

Surgical and Post-Surgical Care

If the cancer has metastasized to the lymph nodes in the neck, those nodes are also removed during surgery. Following a thyroidectomy, patients must take thyroid hormone replacement medication for the rest of their lives to maintain normal metabolic function.

Additional Therapies

For cases where surgery is not sufficient or the cancer has spread further, other treatments may be utilized:

  • Targeted Therapies: Medications such as vandetanib and cabozantinib specifically target DNA changes in the cancer cells.

  • Radiation and Chemotherapy: These may be recommended for advanced cases to help control tumor growth. [2]

A clinical infographic detailing the treatment pathway for medullary thyroid cancer, including total thyroidectomy, lifelong hormone replacement, and targeted drug therapies. – rinnit.com

What is the outlook and prognosis for medullary thyroid cancer?

The prognosis for medullary thyroid cancer depends on the stage at diagnosis, the patient's age, and the success of surgical removal. While MTC is more aggressive than other thyroid cancers, it often grows slowly, allowing for effective management over many years.

Current data suggests a five-year survival rate of approximately 93% for stages 1 through 3. For stage 4, the rate is lower, at about 28%. However, early detection significantly improves these outcomes, and many patients live active lives following successful treatment.

Frequently Asked Questions

1. What is medullary thyroid cancer (MTC)?

MTC is a rare cancer that starts in the C cells located in the medulla (center) of the thyroid gland.

2. How rare is this type of cancer?

Medullary thyroid cancer accounts for only 4% to 10% of all thyroid cancers, with about 1,000 cases diagnosed annually in the U.S.

3. What are the most common symptoms?

The most common sign is a lump or nodule on the thyroid gland, often accompanied by swollen lymph nodes in the neck.

4. Is MTC hereditary?

About 25% of cases are inherited through a genetic condition called Multiple Endocrine Neoplasia type 2 (MEN2).

5. What is the RET gene?

The RET gene is a specific gene that, when mutated, can cause MTC. Mutations can be inherited or acquired randomly.

6. How is MTC diagnosed?

Diagnosis involves neck exams, imaging (ultrasound, CT, MRI), blood tests for calcitonin/CEA, and a needle biopsy.

7. What is the main treatment for MTC?

The primary treatment is a total thyroidectomy, which is the surgical removal of the entire thyroid gland.

8. Will I need to take medication after surgery?

Yes, because the thyroid is removed, you will need lifelong thyroid hormone replacement medication.

9. Can MTC spread to other parts of the body?

Yes, it can spread (metastasize) to neck lymph nodes and, in advanced stages, to other organs.

10. Is MTC more aggressive than other thyroid cancers?

Yes, it is generally more aggressive than papillary or follicular thyroid cancers, but it still often grows slowly.

11. What are targeted therapies?

Targeted therapies are drugs like vandetanib that target specific genetic mutations in cancer cells to stop them from growing.

12. Does radiation therapy work for MTC?

Radiation may be used in advanced cases to control the tumor, though surgery is the preferred first-line treatment.

13. What is the survival rate for MTC?

For stages 1-3, the five-year survival rate is about 93%. It is lower for stage 4, emphasizing the need for early detection.

14. Should my family get tested if I have MTC?

If your MTC is found to be the inherited type (MEN2), genetic testing for biological family members is highly recommended.

15. Can I live a normal life after treatment?

Yes, many people live full, active lives after surgery, provided they maintain their hormone replacement therapy and regular follow-ups.

References

  1. Mayo Clinic Staff. Thyroid cancer - Symptoms and causes. Mayo Clinic. December 23, 2025. https://www.mayoclinic.org/diseases-conditions/thyroid-cancer/symptoms-causes/syc-20354161

  2. Mayo Clinic Staff. Thyroid cancer - Diagnosis and treatment. Mayo Clinic. December 23, 2025. https://www.mayoclinic.org/diseases-conditions/thyroid-cancer/diagnosis-treatment/drc-20354167

  3. Hadoux J, et al. Phase 3 trial of selpercatinib in advanced RET-mutant medullary thyroid cancer. N Engl J Med. 2023;389(20):1851-1861. PMID 37870969. https://doi.org/10.1056/NEJMoa2309719

  4. Wells SA, et al. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J Clin Oncol. 2012;30(2):134-141. PMID 22025146. https://doi.org/10.1200/JCO.2011.35.5040

Medical disclaimer

Medical Disclaimer: The information provided in this article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.

Comments


Spotted an error or a dead link? Tell us

 

Want another health topic explained?

bottom of page